Accessibility Menu
LifeMD logo

LifeMD

(NASDAQ) LFMD

Current Price$4.26
Market Cap$200.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1988)+11%
5 Year-56%
1 Year-63%
1 Month-15%
LifeMD last closing stock price
MetricPriceDate
Last closeUSD 4.152026-07-17
LifeMD stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.56%USD 4.642026-07-10
1 month-15.48%USD 4.912026-06-17
3 month+1.47%USD 4.092026-04-17
Year to date+21.7%USD 3.412025-12-31
1 year-62.61%USD 11.102025-07-17
3 year+6.68%USD 3.892023-07-18
5 year-56.04%USD 9.442021-07-16
Since inception+10.67%USD 3.751988-09-09

LifeMD Financials at a Glance

Market Cap

$200.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$219.42M

Net Income (TTM)

-$16.25M

EPS (TTM)

-$0.42

P/E Ratio

-9.98

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Price

$4.26

Volume

39,632

Open

$4.07

Previous Close

$4.15

Daily Range

$4.03 - $4.27

52-Week Range

$2.56 - $12.72

Estimated Earnings Date

Aug 5, 2026

LFMD News

Foolcom-Featured.png

LifeMD (LFMD) Q2 Revenue Rises 23%

Motley Fool Markets TeamAug 6, 2025

LFMD: Motley Fool Moneyball Superscore

56

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LifeMD

LifeMD helps people talk to doctors and get medicine from home. It focuses on health issues like hair loss and weight management. This service lets patients manage their care using mobile devices.

What Does LifeMD Sell?

  • Subscription Services: Ongoing access to virtual medical care for primary health, weight management, and urgent needs; accounts for 61% of revenue.
  • Health Products: Delivery of prescription and over-the-counter medications for hair loss, skincare, and men's health; accounts for 39% of revenue.
  • Weight Management: Medically supported weight loss programs using medications and personalized coaching for patients.
  • Men's Health: Virtual medical consultations and treatment plans for health conditions through the RexMD brand.
  • Skin and Allergy: Personalized treatments for dermatology, asthma, and immunology through specialized brands.

Strategic Shifts and Growth

  • Launched a weight management program in 2023 to provide metabolic coaching and prescription services.
  • Acquired OHHMD in April 2025 to enter the women's health market with hormone and bone density therapies.
  • Expanded medical weight loss offerings in September 2024 by adding new oral medications to its plans.
  • Sold the majority interest in WorkSimpli in November 2025 to focus entirely on healthcare services.

Standing Out in Telehealth

LifeMD uses a model that combines its own technology with its own pharmacy and clinical infrastructure. This arrangement uses artificial intelligence to help manage medical services and logistics at a large scale.

Q1 2026 Financial Highlights

  • Revenue reached $50.2 million in Q1 2026, down 1.4% from $50.9 million in Q1 2025.
  • Operating loss reached $8.9 million in Q1 2026, worsening from a $1.2 million loss in Q1 2025.
  • Gross profit reached $44.2 million for the quarter ended March 31, 2026, up 3.5% from the previous year.
  • Cash on hand totaled $34.5 million as of March 31, 2026, compared to $36.8 million at the end of 2025.

Evolution of the Business

LifeMD has shifted from a mixed software and health business to a dedicated virtual care provider. By selling non-core assets and expanding medical programs, the company is focusing entirely on scaling its telehealth platform.

AI Generated • May 14, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

389

CEO

Shayna Webb Dray

Website

www.lifemd.com

Headquarters

New York City, NY 10001, US

LFMD Financials

Key Financial Metrics (TTM)

Gross Margin

85.89%

Operating Margin

-5.88%

Net Income Margin

-7.41%

Return on Equity

-172.30%

Return on Capital

-26.02%

Return on Assets

-23.17%

Earnings Yield

-10.02%

Dividend Yield

0.00%

Payout Ratio

-19.11%

Stock Overview

Market Cap

$200.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

48.36M

Volume

39.63K

Avg. Volume

1.03M

Financials (TTM)

Gross Profit

$188.46M

Operating Income

-$12.90M

EBITDA

-$4.22M

Operating Cash Flow

$5.66M

Capital Expenditure

$9.17M

Free Cash Flow

$14.83M

Cash & ST Invst.

$34.48M

Total Debt

$6.17M

LifeMD Performance Analysis

LifeMD annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 119,033,52028.2%
20232023-12-31USD 152,547,00628.2%
20242024-12-31USD 154,824,0751.5%
20252025-12-31USD 194,055,19825.3%
LifeMD sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-5.3%
Q32025-09-30-3.3%
Q42025-12-31-22.1%
Q12026-03-317.0%
LifeMD annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.57-31.3%
20232023-12-31USD -0.70-55.5%
20242024-12-31USD -0.60-14.9%
20252025-12-31USD -0.23-62.0%
LifeMD sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-582.7%
Q32025-09-30-54.7%
Q42025-12-3151.1%
Q12026-03-31-311.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$50.16M

-23.6%

Gross Profit

$42.56M

-25.4%

Gross Margin

84.85%

N/A

Market Cap

$200.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$515.95K

N/A

Employees

389

N/A

Net Income

-$8.87M

-740.7%

EBITDA

-$6.88M

-232.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$34.48M

+0.2%

Total Debt

$6.17M

-75.4%

Accounts Receivable

$9.86M

-3.3%

Inventory

$3.18M

+7.1%

Long Term Debt

$5.50M

-57.7%

Short Term Debt

$670.83K

-94.5%

Return on Assets

-23.17%

N/A

Return on Invested Capital

-62.82%

N/A

Free Cash Flow

$339.45K

+68.8%

Operating Cash Flow

$444.62K

-85.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OMIOwens & Minor, Inc.
$2.68+8.94%
HITIHigh Tide Inc.
$2.20-2.01%
SENSSenseonics Holdings, Inc.
$5.11-0.20%
SMTISanara MedTech Inc.
$25.09+0.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$98.61+0.04%
HLHecla Mining
$14.38+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.94-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$68.98+0.02%

Questions About LFMD

What is the current price of LifeMD?

LifeMD is trading at $4.26 per share.

What is the 52-week range for LifeMD?

Over the past 52 weeks, LifeMD has traded between $2.56 and $12.72.

How much debt does LifeMD have?

As of the most recent reporting period, LifeMD reported total debt of $6.17M.

How much cash does LifeMD have on hand?

LifeMD reported $34.48M in cash and cash equivalents in its most recent financial results.

What is LifeMD’s dividend yield?

LifeMD does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services